Dan Peer
researcher
Dan Peer (Hebrew: דן פאר) is a Professor and the Director of the Laboratory of Precision NanoMedicine at Tel Aviv University (TAU). He is also the Vice President for Research and Development at TAU. In 2017 he co-founded and acts as the managing director of SPARK Tel Aviv, Center for Translational Medicine. From 2016–2020 he was the chair of the TAU Cancer Biology Research Center.
Peer is a past President of the Israeli Chapter of the Controlled Release Society. He was elected to the Israel Young Academy of Science. He is an elected Member of the National Academy of Engineering (USA), and a Fellow of the National Academy of Inventors (USA) and the Controlled Release Society.
Research work
Peer pioneered the field of active cellular targeting of RNA payloads into specific cell types. His lab was among the first to demonstrate immunomodulation through a systemic delivery of RNA-loaded targeted nanocarriers. The team also pioneered the use of RNAi to reprogram immune cells and discover new therapeutic modalities. In addition, his lab was the first to show systemic, cell specific delivery of mRNA in an animal.
Begin with the source’s own compact description: “Dan Peer” is researcher. The dossier treats that line as a proposition to test through Peer and researcher, not as a finished interpretation.
Why this record matters
The phrase “researcher” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Biographical claims are most persuasive when dates, appointments and relationships can be traced to records created close to the events described. The source revision retrieved here is dated Aug 20, 2026. The linked authority identifier is Q43193344. VIAF identifies the subject as 98348567. The Library of Congress control number is no2012058597. 1 of 4 selected statements include explicit references; 0 carry qualifiers and 0 use preferred rank. The first chronological checks are 2017, 2016 and 2020.
A concise life account rarely captures disputed attribution, private networks or the changing language used to describe a career. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Read biographical claims against dates, named institutions and the cited references. Distinguish a subject’s later reputation from evidence produced during their lifetime.
- Establishing names and roles
- Building a first chronology
- Locating cited institutions
Personal papers, civil or court records, institutional files and the scholarship cited by the source.
Three-step research path
- Establish the record: confirm the title “Dan Peer”, its source revision and the description used here.
- Expand the search: follow Dan Peer primary sources, Dan Peer archive and Peer research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Dan Peer”?
- Which claims depend on a single source or contested interpretation?
- Which primary records establish identity, chronology and institutional ties?
Search terms from this dossier
This entry incorporates text from “Dan Peer” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.